As biopharmaceutical manufacturers embrace new technologies, mycoplasma testing continues to present challenges at various stages in the production process for cell therapy products. Risk assessment is a valuable tool for the selection and optimization of rapid mycoplasma testing methods. Learn more about pharmaceutical manufacturing and testing in this eBook.
Please check the highlighted fields and try again.
Please fill out the information below to request information on the products you selected. If you are already registered, or have requested a quote before, login and this information will be filled out for you.
Please enter the name of the company or institution you work at.
Please enter your mailing address.
Please enter the e-mail address you would like to be contacted at.
Please enter the phone number you would like to be contacted at.
By submitting my personal data to CompareNetworks, I acknowledge it will be shared with the Thermo Fisher Scientific group for processing in accordance with the Thermo Fisher Scientific Privacy Policy. I can withdraw my consent and unsubscribe at any time by emailing reply@thermofisher.com.
Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.